OUTLOOK THERAPEUTICS Valuation
| OTLK Stock | USD 2.06 0.17 8.99% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. OUTLOOK THERAPEUTICS INC holds a recent Real Value of $2.46 per share. The prevailing price of the company is $2.06. Our model determines the value of OUTLOOK THERAPEUTICS INC from reviewing the company fundamentals such as Return On Asset of -0.84, return on equity of -0.0365, and Shares Outstanding of 24.91 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting OUTLOOK THERAPEUTICS's valuation include:
Price Book 10.1912 | Enterprise Value | Enterprise Value Ebitda (4.13) | Price Sales 13.2716 | Forward PE 2.8498 |
Undervalued
Today
Please note that OUTLOOK THERAPEUTICS's price fluctuation is extremely dangerous at this time. Calculation of the real value of OUTLOOK THERAPEUTICS INC is based on 3 months time horizon. Increasing OUTLOOK THERAPEUTICS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
OUTLOOK THERAPEUTICS's intrinsic value may or may not be the same as its current market price of 2.06, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.06 | Real 2.46 | Target 3.75 | Hype 1.93 |
The intrinsic value of OUTLOOK THERAPEUTICS's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence OUTLOOK THERAPEUTICS's stock price.
Estimating the potential upside or downside of OUTLOOK THERAPEUTICS INC helps investors to forecast how OUTLOOK stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OUTLOOK THERAPEUTICS more accurately as focusing exclusively on OUTLOOK THERAPEUTICS's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use OUTLOOK THERAPEUTICS's intrinsic value based on its ongoing forecasts of OUTLOOK THERAPEUTICS's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against OUTLOOK THERAPEUTICS's closest peers.
OUTLOOK THERAPEUTICS Cash |
|
OUTLOOK Valuation Trend
Knowing OUTLOOK THERAPEUTICS's actual value is paramount for traders when making sound investment determinations. Using both OUTLOOK THERAPEUTICS's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
OUTLOOK THERAPEUTICS Total Value Analysis
OUTLOOK THERAPEUTICS INC is now expected to have valuation of 61.88 M with market capitalization of 47.07 M, debt of 297.83 B, and cash on hands of 26.02 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the OUTLOOK THERAPEUTICS fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
61.88 M | 47.07 M | 297.83 B | 26.02 M |
OUTLOOK THERAPEUTICS Investor Information
About 36.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.06. OUTLOOK THERAPEUTICS INC last dividend was issued on the 18th of March 2019. The entity had 1:20 split on the 14th of March 2024. Based on the key indicators related to OUTLOOK THERAPEUTICS's liquidity, profitability, solvency, and operating efficiency, OUTLOOK THERAPEUTICS INC may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.OUTLOOK THERAPEUTICS Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. OUTLOOK THERAPEUTICS has an asset utilization ratio of 2.0E-5 percent. This suggests that the Company is making $0.0 for each dollar of assets. An increasing asset utilization means that OUTLOOK THERAPEUTICS INC is more efficient with each dollar of assets it utilizes for everyday operations.OUTLOOK THERAPEUTICS Ownership Allocation
OUTLOOK THERAPEUTICS owns a total of 24.91 Million outstanding shares. OUTLOOK THERAPEUTICS has large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.OUTLOOK THERAPEUTICS Profitability Analysis
The company reported the previous year's revenue of 5.85 M. Net Loss for the year was (75.37 T) with loss before overhead, payroll, taxes, and interest of (42.33 M).About OUTLOOK THERAPEUTICS Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of OUTLOOK THERAPEUTICS INC. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of OUTLOOK THERAPEUTICS INC based exclusively on its fundamental and basic technical indicators. By analyzing OUTLOOK THERAPEUTICS's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of OUTLOOK THERAPEUTICS's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of OUTLOOK THERAPEUTICS. We calculate exposure to OUTLOOK THERAPEUTICS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OUTLOOK THERAPEUTICS's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -39.8 K | -37.8 K | |
| Pretax Profit Margin | (5.36) | (5.62) | |
| Operating Profit Margin | (5.12) | (5.38) | |
| Net Loss | (4.87) | (5.12) | |
| Gross Profit Margin | 0.90 | 0.79 |
OUTLOOK THERAPEUTICS Growth Indicators
Investing in growth stocks can be very risky. If the company such as OUTLOOK THERAPEUTICS does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 18.5 B | |
| Forward Price Earnings | 2.8498 |
OUTLOOK THERAPEUTICS Current Valuation Indicators
OUTLOOK THERAPEUTICS's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final OUTLOOK THERAPEUTICS's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as OUTLOOK THERAPEUTICS, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use OUTLOOK THERAPEUTICS's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes OUTLOOK THERAPEUTICS's worth.When determining whether OUTLOOK THERAPEUTICS INC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if OUTLOOK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Outlook Therapeutics Inc Stock. Highlighted below are key reports to facilitate an investment decision about Outlook Therapeutics Inc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.06) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.